A glycerophosphoethanolamine obtained by formal condensation of the carboxy group of hexadecanoic acid with the amino group of 1-[(1Z)-octadecenoyl]-2-oleoyl-sn-glycero-3-phosphoethanolamine.


CDP-dipalmitoyl-sn-glycerol

A CDP-diacylglycerol in which both of the phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl).


A 3-sn-phosphatidyl-L-serine compound with a palmitoyl group at the 1-position and an oleoyl group at the 2-position.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as oleoyl.


phosphatidylinositol 34:2

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 34 carbon atoms and 2 double bonds.


A 3-sn-phosphatidyl L-serine in which the phosphatidyl acyl groups at both positions 1 and 2 are specified as hexadecanoyl (palmitoyl).


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as octadecanoyl (stearoyl) and 9Z-octadecenoyl (oleoyl) respectively.


triacylglycerol 52:2

A triglyceride in which the three acyl groups contain a total of 52 carbons and 2 double bonds.


linoleoyl-containing glycerolipid

A glycerolipid where one of the acyl groups is specified as linoleoyl


A triglyceride where at least one of the primary OH groups in the glycerol backbone has a linoleoyl chain.


phosphatidylethanolamine (17:1/18:1)

A phosphatidylethanolamine 35:2 in which the acyl group at C-1 contains 17 carbons and 1 double bond while that at C-2 contains 18 carbons and 1 double bond.


A glycerophosphoinositol phosphate having a 1-O,2-O-dioctanoyl-sn-glycero-3-phospho moiety attached at the 1-position of 1D-myo-inositol 4,5-bis(phosphate).


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as caproyl (hexanoyl) while the phosphatidyl acyl groups at position 1 and 2 are specified as palmitoyl (hexadecanoyl) and linoleoyl (9Z,12Z-octadecadienoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as (9Z)-hexadec-9-enoyl (pamitoleoyl) and octadecanoyl (stearoyl) respectively.


A glycerophosphoglycerol that is sn-glycero-3-phosphoglycerol in which positions 1 and 2 are substituted by unspecified acyl and alkyl groups, and in which the positions of the acyl and alkyl groups are also unspecified.


A 3-acyl-sn-glycerol that has octanoyl as the 3-acyl group.


phosphatidylglycerol O-36:1

An alkyl,acyl-sn-glycero-3-phosphoglycerol in which the alkyl or acyl groups at positions 1 and 2 contain a total of 36 carbons and 1 double bond.


N-acyllysophosphatidylethanolamine

Any glycerophospholipid consisting of a lysophosphatidylethanolamine in which one of the amino hydrogens is replaced by an acyl group.


OMPT

A glycerophospholipid obtained by formal condensation of the carboxy group of oleic acid with the primary hydroxy group of (2S)-2-methylglycero-3-phosphothionate.


A 1-acyl-2-hexadecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as oleoyl (9Z-octadecaenoyl).


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as tetradecanoyl (myristoyl) and hexadecanoyl (palmitoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are both specified as (9Z,11Z)-octadecadienoyl.


An alkyl,acyl-sn-glycero-3-phosphoserine in which unspecified alkyl and acyl groups are located at positions 1 and 2 respectively.


triacylglycerol 60:12

A triglyceride in which the three acyl groups contain a total of 60 carbons and 12 double bonds.


A phosphatidic acid in which one acyl group has 18 carbons and is fully saturated while the other has 22 carbons and 4 double bonds.


A triglyceride in which the acyl groups at positions 1 and 3 are specified as oleoyl while that at position 2 is specified as palmitoyl.


phosphatidylethanolamine 39:6

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the two acyl groups contain a total of 39 carbons and 6 double bonds.


A 2-monoglyceride where the acyl group is hexadecanoyl (palmitoyl).


A 1-phosphatidyl-D-myo-inositol in which the acyl group at position 1 is unspecified while that at position 2 is specified as palmitoyl (hexadecanoyl).


lysophosphatidylethanolamine 22:4

A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 22 carbons and 4 double bonds.


triacylglycerol 47:2

A triglyceride in which the three acyl groups contain a total of 47 carbons and 4 double bonds.


phosphatidylserine 42:9

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 42 carbons and 9 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituent both at positions 1 and 2 is specified as (6Z)-octadecenoyl respectively.


triacylglycerol 60:3

A triglyceride in which the three acyl groups contain a total of 60 carbons and 3 double bonds.


A phosphatidylglycerol (18:3/16:1) in which the 1- and 2-acyl groups are specified as alpha-linolenoyl and (3E)-hexadecenoyl respectively.


A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 1-acyl group is specified as linoleoyl.


name: phosphatidylethanolamine amidated glycine zwitterion


lysophosphatidic acid

A member of the class of lysophosphatidic acids obtained by hydrolytic removal of one of the two acyl groups of any phosphatidic acid. A 'closed' class.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (5Z,8Z,11Z,14Z)-eicosatetraenoyl (arachidonoyl).


phosphatidylserine 40:1

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 1 double bond.


phosphatidylglycerol phosphate

A phosphatidylglycerol in which one of the hydroxy groups of the glycerol moiety has been converted to the corresponding dihydrogen phosphate.


phosphatidylserine 38:3

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 38 carbon atoms and 3 double bonds.


phosphatidylethanolamine (15:0/20:1)

A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 15 carbons and no double bonds while that at C-2 contains 20 carbons and 1 double bond.


A 1-alkyl-2-acyl-sn-glycero-3-phosphserine in which the alkyl and acyl groups are specified as (1Z)-octadecenyl and oleoyl respectively.


name: Glycerol 1-(9Z-octadecenoate) 2-hexadecanoate 3-octadecanoate


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as icosanoyl (arachidoyl).


triacylglycerol 53:7

A triglyceride in which the three acyl groups contain a total of 53 carbons and 7 double bonds.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as palmitoyl while the phosphatidyl acyl groups are both specified as oleoyl.


1-palmitoylglycerol 3-phosphate

A monoacylglycerol phosphate having palmitoyl as the acyl group on O-1 and with the phosphate group on O-3.


triacylglycerol 51:2

A triglyceride in which the three acyl groups contain a total of 51 carbons and 2 double bonds.


A glycerolipid where one of the acyl groups is specified as (8Z,11Z,14Z)-icosatrienoyl


A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and linoleoyl respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which both acyl groups are specified as oleoyl.


phosphatidylinositol 34:0

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 34 carbon atoms and no double bonds.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as oleoyl and palmitoyl respectively.


A plasmalogen that has no fatty acyl chain at sn-2 and where the glycerolipid is not defined, R3 can be H or a phospholipid.


phosphatidylethanolamine (18:0/20:4)

A phosphatidylethanolamine 38:4 in which the acyl group at C-1 contains 18 carbons and no double bonds while that at C-2 contains 20 carbons and 4 double bonds.


A 1-(Z)-alk-1-enyl-2-oleoyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 1-(1Z-hexadecenyl)-2-oleoyl-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.


A 1-phosphatidyl-1D-myo-inositol 4-phosphate in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and oleoyl respectively.


phosphatidylserine 40:6

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 6 double bonds.


triacylglycerol 51:4

A triglyceride in which the three acyl groups contain a total of 51 carbons and 4 double bonds.


A triacylglycerol 54:8 in which the acyl groups at positions 1, 2 and 3 are specified as tetradecanoyl, octadecadienoyl and docosahexaenoyl respectively.


phosphatidylserine (20:0/20:5)

A phosphatidylserine 40:5 in which the acyl group at C-1 contains 20 carbons and no double bonds while that at C-2 contains 20 carbons and 5 double bonds.


triacylglycerol 56:2

A triglyceride in which the three acyl groups contain a total of 56 carbons and 2 double bonds.


lysophosphatidylglycerol 12:0

A lysophosphatidylglycerol in which the acyl group has a fully saturated C12 chain and is attached to the glycero moiety at either position 1 or 2.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are both specified as hexadecanoyl (palmitoyl).


lysophosphatidic acid 18:0

A lysophosphatidic acid in which the acyl group (position not specified) contains 18 carbons and no double bonds.


phosphatidylglycerol P-34:3

1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoglycerol in which the alk-1-enyl and acyl groups at positions 1 and 2 contain 34 carbon atoms in total with 3 additional double bonds.


1-phosphatidyl-1D-myo-inositol in which the 2-acyl group is specified as (5Z,8Z,11Z,14Z)-eicosatetraenoyl (arachidonoyl).


An optically active form of 1,2-distearoylphosphatidylethanolamine having (S)-configuration.


A phosphatidylglycerol (18:3/16:0) in which the 1- and 2-acyl groups are specified as alpha-linolenoyl and hexadecanoyl respectoively.


triacylglycerol 54:1

A triglyceride in which the three acyl groups contain a total of 54 carbons and 1 double bond.


A triacyl-sn-glycerol in which the which the acyl groups at positions 1, 2 and 3 are specified as tetradecanoyl, hexadecanoyl and octadecanoyl respectively.


GLYCERYL TRIOLEATE

A triglyceride formed by esterification of the three hydroxy groups of glycerol with oleic acid. Triolein is one of the two components of Lorenzo's oil.


triacylglycerol 46:0

A triglyceride in which the three acyl groups contain a total of 46 carbons and 0 double bonds.


A galactoglycerolipid in which positions 1 and 2 are substituted by unspecified acyl and alkyl groups, the positions of which are also unspecified.


triacylglycerol 55:8

A triglyceride in which the three acyl groups contain a total of 55 carbons and 8 double bonds.


triacylglycerol 50:5

A triglyceride in which the three acyl groups contain a total of 50 carbons and 5 double bonds.


A 3-acyl-sn-glycerol in which the acyl group is (9Z)-octadec-9-enoyl.


A 1-(alk-1-enyl)-sn-glycerol in which the alk-1-enyl group has Z geochemistry.


A triacylglycerol 54:8 in which the acyl groups at positions 1 and 2 are specified as hexadecenoyl, while that at position 3 is docosahexaenoyl.


phosphatidylinositol 44:0

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 44 carbon atoms and no double bonds.


A triacylglycerol 56:3 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl, while that at position 3 is docosapentaenoyl.


A glycerolipid where one of the acyl groups is specified as (7Z,10Z,13Z)-hexadecatrienoyl.


A 3-sn-phosphatidyl-L-serine in which the two phosphatidyl acyl groups are specified as octanoyl.


A 1-monoglyceride that has decanoyl (capryl) as the acyl group.


phosphoinositide

Any phosphatidylinositol that is phosphorylated at one or more of the hydroxy groups of inositol.


A 1-monoglyceride that has octadecadienoyl (linoleoyl) as the acyl group.


phosphatidylethanolamine (17:0/18:1)

A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 17 carbons and no double bonds while that at C-2 contains 18 carbons and 1 double bond.


phosphatidylglycerol 14:0/18:1

A phosphatidylglycerol 32:1 in which the acyl group at position 1 contains 14 carbons and no double bonds while that at position 2 contains 18 carbons and 1 double bond.


A 3-sn-phosphatidyl-L-serine in which the acyl substituents at positions 1 and 2 are specified as heptadecanoyl and arachidonoyl respectively.


triacylglycerol 60:10

A triglyceride in which the three acyl groups contain a total of 60 carbons and 10 double bonds.


A 1-alkyl-2-acetylglycerol in which the 1-alkyl group is specified as palmityl (hexadecyl).


A 1-monoglyceride where the acyl group is arachidonoyl.


triacylglycerol 45:0

A triglyceride in which the three acyl groups contain a total of 45 carbons and 0 double bonds.


A triacylglycerol 53:3 in which the acyl groups at positions 1, 2 and 3 are specified as heptadecanoyl, octadecenoyl and octadecadienoyl respectively.


phosphatidylethanolamine 40:9

A phosphatidylethanolamine in which the two acyl groups contain a total of 40 carbons and 9 double bonds.


A triglyceride in which the acyl groups at positions 1 and 2 are specified as oleoyl while that at position 3 is specified as palmitoyl.


dimethyl cardiolipin

The dimethyl phosphate ester of cardiolipin.


phosphatidylinositol 38:4

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 38 carbon atoms and 4 double bonds.


A 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are both specified as octanoyl.


A triacylglycerol 58:11 in which the acyl groups at positions 1, 2 and 3 are specified as hexadecenoyl, icosatetraenoyl and docosahexaenoyl respectively.


phosphatidylserine 38:5

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 38 carbon atoms and 5 double bonds.


1,2-diacyl-sn-glycerol 3-phosphate

An sn-glycerol 3-phosphate compound having unspecified O-acyl groups at the 1- and 2-positions.


A phosphatidylinositol 3-phosphate in which both phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl)


A 3-acyl-sn-glycerol that is the R-enantiomer of 1-monolinolein.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which both the acyl groups specified is (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.


triacylglycerol 54:8

A triglyceride in which the three acyl groups contain a total of 54 carbons and 8 double bonds.


phosphatidylethanolamine 19:1

A 1,2-diacyl-sn-glycero-3-phosphoethanolaminein which the two phosphatidyl acyl groups contain a total of 19 carbons and 1 double bond.


lysophosphatidylethanolamine

A glycerophosphoethanolamine resulting from partial hydrolysis of a phosphatidylethanolamine, which removes one of the fatty acid groups. The structure is depicted in the image where R(1) = acyl, R(2) = H or where R(1) = H, R(2) = acyl.


lysophosphatidylglycerol 14:0

A lysophosphatidylglycerol in which the acyl group has a fully saturated C14 chain and is attached to the glycero moiety at either position 1 or 2.


triacylglycerol 44:4

A triglyceride in which the three acyl groups contain a total of 44 carbons and 4 double bonds.


triacylglycerol 38:0

A triglyceride in which the three acyl groups contain a total of 38 carbons and no double bonds.


Any glycerolipid where the 1-acyl group is specified as linoleoyl


A glycerolipid where one of the acyl groups is specified as (9Z,12E)-hexadecadienoyl.


triacylglycerol 58:11

A triglyceride in which the three acyl groups contain a total of 58 carbons and 11 double bonds.


A triacylglycerol 58:11 in which the acyl groups at positions 1, 2 and 3 are specified as octadecadienoyl, octadecatrienoyl and docosahexaenoyl respectively.


phosphatidylethanolamine (16:1/20:4)

A phosphatidylethanolamine in which one acyl group has 16 carbons and 1 double bond while the other has 20 carbons and 4 double bonds.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively.


A 1-phosphatidyl-1D-myo-inositol 5-phosphate in which both phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl).


A 1-alkyl-3-acylglycerol in which the alkyl and acyl groups are specified as palmityl (hexadecyl) and oleoyl.


phosphatidylethanolamine (18:2/18:2)

A phosphatidylethanolamine 36:4 in which both acyl groups contain 18 carbons and 2 double bonds.


1-stearoyl 2-acylglycerolipid

Any glycerolipid where the 1-acyl group is specified as stearoyl (octadecanoyl).


A lysophosphatidylethanolamine 18:1 in which the acyl group is located at position 1.


A triacylglycerol 62:10 in which the acyl group at position 1 is specified as octadecanoyl while those at positions 2 and 3 are both docosapentaenoyl groups.


A glycerolipid where one of the acyl groups is specified as (9Z,11E,13E,15Z)-octadecatetraenoyl.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as oleoyl and stearoyl respectively.


A 1-acyl-sn-glycerol that has octanoyl as the 1-acyl group.


A 1-acyl-sn-glycerol that is the S-enantiomer of 1-myristoyl glycerol.


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as linolenoyl (9Z,12Z,15Z-octadecatrienoyl).


lysophosphatidylethanolamine 18:0

A lysophosphatidylethanolamine in which the acyl group has a fully saturated C18 chain and is attached to the glycero moiety at either position 1 or 2.


lysophosphatidylinositol 16:1

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 16 carbons and 1 double bond.


A 1-monoglyceride resulting from the formal condensation of 1-(all-cis-docosa-7,10,13,16-tetraenoic acid (adrenic acid) with one of the primary hydroxy groups of glycerol.


A triacylglycerol 62:12 in which the acyl group at position 1 is specified as octadecanoyl while those at positions 2 and 3 are both docosahexaenoyl groups.


lysophosphatidylglycerol 18:1/0:0

A lysophosphatidylglycerol 18:1 in which the acyl group is located at position 1.


lysophosphatidic acids

Any monoacylglycerol phosphate obtained by hydrolytic removal of one of the two acyl groups of any phosphatidic acid or derivatives therein.


A triacylglycerol 54:5 in which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, octadecadienoy and icosatrienoyl respectively.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the 1- and 2-acyl substituent are specified as oleoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively; major species at pH 7.3.


triacyl-sn-glycerol

Any optically active triglyceride that has R-configuration.


bacilysocin

A carboxylic ester resulting from the formal condensation of the carboxylic acid group of 12-methyltetradecanoic acide with one of the primary alcoholic hydroxy groups of glycerophosphoglycerol. An antibiotic obtained from Bacillus subtilis 168, it has particular activity against certain fungi. The stereochemistries of the hydroxy groups at positions C-2 and C-2' and the methyl group at position C-12 have not been determined.


A phosphatidylinositol mannoside consisting of alpha-D-mannopyranose and 6-acyl-alpha-D-mannopyranose residues attached at positions 2 and 6 respectively of 1-phosphatidyl-1D-myo-inositol via glycosidic linkages.


lysophosphatidylethanolamine 12:0

A lysophosphatidylethanolamine in which the acyl group has a fully saturated C12 chain and is attached to the glycero moiety at either position 1 or 2.


A 1,2-diacyl-sn-glycerol 3-phosphate in which both phosphatidyl acyl groups are specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.


mannosyl diphosphorylinositol ceramide

Any lipid with a phosphodiester bridge between an inositol residue and the ceramide group which contains two phosphoryl groups and a mannose residue.


A 1-O-(alk-1-enyl)-2-O-acylglycerol having a cis,cis-(1,9-octadecadienyl) group at the 1-position and a stearoyl group at the 2-position.


lysophosphatidylglycerol

A glycerophosphoglycerol resulting from partial hydrolysis of a phosphatidylglycerol, which removes one of the fatty acid groups. The structure is depicted in the image where R1 = acyl, R2 = H or where R1 = H, R2 = acyl.


A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is specified as 9Z,12Z-octadecadienoyl (linoleoyl).


2-acylglycerol 16:1

A 2-monoglyceride in which the acyl group contains 16 carbons and 1 double bond.


triacylglycerol 48:0

A triglyceride in which the three acyl groups contain a total of 48 carbons and 0 double bonds.


An N-acylphosphatidylethanolamine in which the N-acyl group and the phosphatidyl acyl groups are specified as oleoyl (9Z-octadecenoyl).


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as hexadecanoyl while the phosphatidyl acyl groups at position 1 and 2 are specified as hexadecanoyl and (9Z,12Z-octadecadienoyl) respectively.


A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl and acyl groups are specified as (1Z-octadecenyl) and arachidonoyl respectively.


2-acylglycerol 18:2

A 2-monoglyceride in which the acyl group contains 18 carbons and 2 double bonds.


A glycerophospholipid obtained by formal condensation of the carboxy group of any carboxylic acid with the amino group of any 1-[(1Z)-alkenyl]-2-acyl-sn-glycero-3-phosphoethanolamine.


An alkyl,acyl-sn-glycero-3-phospho-1D-myo-inositol in which unspecified acyl and alkyl groups are located at positions 1 and 2 respectively.


dioleoyl phosphatidylglycerol

A phosphatidylglycerol in which the phosphatidyl acyl groups are both oleoyl.


A 1-O-(alk-1-enyl)-2-palmitoyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl group has Z geochemistry.


phosphatidylinositol 5-phosphate

A phosphatidylinositol monophosphate carrying the phosphate group at the 5-position.


A 1-[(Z)-alk-1-enyl]-sn-glycero-3-phospho-(N-acyl)ethanolamine in which the alk-1-enyl and N-acyl groups are specified as 1Z-octadecenyl and hexadecanoyl respectively.


lysophosphatidylethanolamine 20:4

An acyl-sn-glycero-3-phosphoethanolamine in which the acyl group contains twenty carbons and four double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphoethanolamine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphoethanolamine.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and (11Z)-octadecenoyl respectively.


triacylglycerol 62:13

A triglyceride in which the three acyl groups contain a total of 62 carbons and 13 double bonds.


A 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are both specified as octanoyl.


A dialkylglycerophosphoethanolamine in which the alkyl groups are hexadecyl and the glycerol core has sn stereochemistry with the phosphoethanolamine unit at position 3.


1-phosphatidyl-1D-myo-inositol in which the 1- and 2-acyl groups are specified as (5Z,8Z,11Z,14Z,17Z)-docosapent-5,8,11,14,17-enoyl and octadecanoyl (stearoyl) respectively.


A phosphatidylethanolamine 38:2 in which one acyl group has 18 carbons and 1 double bond while the other has 20 carbons and 1 double bond (position not specified).


A glycerolipid where one of the acyl groups is specified as omega-3-arachidonoyl


A 3-[alpha-D-galactosyl-(1->6)-beta-D-galactosyl]-1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are both specified as linoleoyl.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and (8Z,11Z,14Z)-icosatrienoyl respectively.


A 1-(1Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group is specified as acetyl.


A monoglyceride that is 1-oleoyl-sn-glycerol in which the hydroxyl hydrogen at position 2 is replaced by an arachidonyl group.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 5Z,8Z,11Z,14Z-eicosatetraenoyl (arachidonoyl) respectively.


A chiral alkylglycerol having the alkyl group at the 1-position.


A fatty acid ester resulting from the formal condensation of the hydroxy group at position-1 of glycerol with the carboxy group of (15Z)-tetracosenoic acid.


phosphatidylethanolamine 38:2

A phosphatidylethanolamine in which the two acyl groups contain a total of 38 carbons and 2 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphate in which the acyl groups at positions 1 and 2 are specified as capryl (decanoyl).


A 1-phosphatidyl-1D-myo-inositol 5-phosphate in which both phosphatidyl acyl groups are specified as linoleoyl.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as oleoyl; major species at pH 7.3.


dihexadecanoyl phosphatidic acid

A phosphatidic acid in which the phosphatidyl acyl groups are both palmitoyl (hexadecanoyl).


triacylglycerol 62:15

A triglyceride in which the three acyl groups contain a total of 62 carbons and 15 double bonds.


A 2-monolysocardiolipinin which the remaining phosphatidyl acyl groups at positions 1 and 1' are specified as linoleoyl while that at position 2' is  specified as oleoyl.


phosphatidylethanolamine (18:2/20:4)

A phosphatidylethanolamine 38:6 in which the acyl group at C-1 contains 18 carbons and 2 double bonds while that at C-2 contains 20 carbons and 4 double bonds.


lysophosphatidylethanolamine P-34:3

A 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoethanolamine in which the alkenyl group contains 34 carbons and has 3 additional double bonds.


triacylglycerol 48:1

A triglyceride in which the three acyl groups contain a total of 48 carbons and 1 double bond.


phosphatidylinositol (18:2/18:2)

A phosphatidylinositol 36:4 in which both acyl groups contain 18 carbons and 2 double bonds.


A phosphatidylglycerol (18:2/16:1) in which the 1- and 2-acyl groups are specified as linoleoyl and (3E)-hexadecenoyl respectively.


A triacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl while that at position 3 is specifed as myristoyl.


phosphatidylglycerol 16:0/16:1

A phosphatidylglycerol 32:1 in which the acyl group at position 1 contains 16 carbons and no double bonds while that at position 2 contains 16 carbons and 1 double bond.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (11R)-hydroxy-(5Z,8Z,12E,14Z)-icosatetraenoyl.


A CDP-diacylglycerol in which the acyl groups at positions 1 and 2 are specified as tetradecanoyl.


phosphatidylglycerol 34:4

A phosphatidylglycerol in which the two acyl groups contain 34 carbon atoms and 4 double bonds.


A 1-acyl-sn-glycerophosphoserine compound having an oleoyl substituent at the 1-hydroxy position.


A 1-alkyl-sn-glycero-3-phosphoethanolamine in which the alkyl group at C-1 is specified as hexadecyl.


A glucosaminylphosphatidylinositol compound consisting of D-glucosamine joined to 1-phosphatidyl-1D-myo-inositol via a (1->6)-alpha-linkage.


An N-glycosylated dialkylglycerophosphoethanolamine in which the dialkylglycerophosphoethanolamine is AOPE and the glycosylating saccharide is the branched nonasaccharide alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc.


A phosphatidylethanolamine 37:3 in which the acyl groups at positions 1 and 2 are specified as nonadecanoyl and (9Z,12Z,15Z)-octadecatrienoyl, respectively.


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (8Z,11Z,14Z,17Z)-icosatetraenoyl and arachidoyl (icosanoyl) respectively.


glycosylmonoradylglycerol

Any glycosylmonoglyceride in which the glycosyl moiety is attached to one of the primary hydroxy groups.


tripropionin

A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by propionic acid.


A 1-monoglyceride in which the acyl group is specified as (9Z)-hexadecenoyl.


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as arachidonoyl.


phosphatidylinositol pentamannoside

A glycosylphosphatidylinositol having a pentamannose moiety of unspecified composition as the glycosyl fragment; obtained via extraction of the cell wall of Mycobacterium bovis.


A lysoglycerophospholipid that has an acyl group at position sn-1.


name: phosphatidyl (3,4) inositol bisphosphate

description: A 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are both specified as hexadecanoyl (palmitoyl).


phosphatidylethanolamine 38:3

A phosphatidylethanolamine in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 3 double bonds.


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as linoleoyl.


An alkylglycerol having the alkyl group located at either the sn-1 or sn-3 position.


A CDP-diacylglycerol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as palmitoyl and arachidonoyl respectively.


A 1-acyl-sn-glycerol that has hexadecanoyl (palmitoyl) as the 1-acyl group.


1-acylglycerol 16:1

A 1-monoglyceride in which the acyl group contains 16 carbons and 1 double bond.


name: Pyrrolidinium, 1-[(7r)-7-(acetyloxy)-4-hydroxy-4-oxido-3,5,9-trioxa-4-phosphapentacos-1-yl]-1-methyl-, inner salt


phosphatidylethanolamine (16:0/20:1)

1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 20 carbons and 1 double bond.


triacylglycerol 58:5

A triglyceride in which the three acyl groups contain a total of 58 carbons and 5 double bonds.


triacylglycerol 49:1

A triglyceride in which the three acyl groups contain a total of 49 carbons and 1 double bond.


A 1-acyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1-acyl substituent is specified as hexadecanoyl (palmitoyl).


2-acylglycerol 16:0

A 2-monoglyceride in which the acyl group contains 16 carbons and is fully saturated.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 5Z,8Z,11Z,14Z-eicosatetraenoyl (arachidonoyl) respectively.


A 2-acyl-sn-glycero-3-phospho-D-myo-inositol that has palmitoleoyl as the acyl group.


1-acylglycerol 16:0

A 1-monoglyceride in which the acyl group contains 16 carbons and is fully saturated.


A digalactosylglycerol derivative in which the digalactosyl moiety is alpha-D-galactosyl-(1->6)-beta-D-galactosyl at O-3, with O-1 and O-2 both acylated.


tricaproin

A triglyceride obtained by condensation of each of the three hydroxy groups of glycerol with hexanoic (caproic) acid.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and palmitoyl.


A 1-alkyl-sn-glycero-3-phosphoethanolamine in which the alkyl substituent can be any Z-alk-1-enyl group.


triacylglycerol 56:5

A triglyceride in which the three acyl groups contain a total of 56 carbons and 5 double bonds.


lysophosphatidylethanolamine 16:0

A lysophosphatidylethanolamine in which the acyl group has a fully saturated C16 chain and is attached to the glycero moiety at either position 1 or 2.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and heptadecanoyl respectively.


phosphatidylglycerol (18:1/17:1)

A phosphatidylglycerol 35:2 in which the acyl group at C-1 contains 18 carbons and 1 double bond while that at C-2 contains 17 carbons and 1 double bond.


A phosphatidylinositol 36:1 in which one acyl group has 18 carbons and is fully saturated while the other has 18 carbons and 1 double bond (position not specified).


phosphatidic acid 36:2

A phosphatidic acid in which the two acyl groups contain a total of 36 carbons and 2 double bonds.


A 2-acyl-sn-glycero-3-phosphoserine in which the acyl group is specified as oleoyl.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as heptadecanoyl and oleoyl respectively.


2-lysophosphatidic acid

Any member of the class of lysophosphatidic acids which has a free hydroxy group at the 2-position of the glycerol moiety.


An inositol compound having alpha-mannosyl-(1->2)-alpha-mannosyl-(1->6)-alpha-2-(2-aminoethylphosphoryl)mannosyl-beta-glucosaminyl and phosphatidyl substituents on its hydroxy groups.


A glycerophosphoethanolamine having an unspecified O-acyl substituent at the 1-position of the glycerol fragment.


Any alkyldiacylglyceride in which the alkyl group is located at position 1 and the acyl groups at positions 2 and 3.


A 1-alkyl-2,3-diacylglycerol with the alkyl substituent at the sn-1 position and the two acyl substituents at the sn-2 and sn-3 positions.


A 3-sn-phosphatidyl-L-serine in which the 1- and 2-acyl groups are octadecenoyl and docosenoyl respectively.


A triacylglycerol 52:1 in which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, octadecanoyl and octadecenoyl respectively.


An sn-glycerophosphoserine compound having an acyl substituent at the 1-hydroxy position.


A triglyceride formed by acylation of the three hydroxy groups of glycerol with linoleic acid.


lysophosphatidylglycerol 16:1

A lysophosphatidylglycerol in which the acyl group (position of attachment not specified) contains 16 carbons and 1 double bond.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as myristoyl and oleoyl respectively.


An alkyl,acyl-sn-glycero-3-phospho-1D-myo-inositol-5-phosphate in which unspecified alkyl and acyl groups are located at positions sn-1 and sn-2 respectively. Major microspecies at pH 7.3


phosphatidylserine 40:2

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 2 double bonds.


triacylglycerol 53:8

A triglyceride in which the three acyl groups contain a total of 53 carbons and 8 double bonds.


Any 1-(alk-1-enyl)glycerol having 2S-configuration.


phosphatidylethanolamine (16:0/22:6)

A phosphatidylethanolamine 38:6 in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 22 carbons and 6 double bonds.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and linoleoyl.


The deacylated homologue of mono(p-azobenzenearsonic acid)-L-tyrosylphosphatidylethanolamine.


phosphatidylinositol 39:4

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 39 carbon atoms and 4 double bonds.


phosphatidylethanolamine 42:5

A phosphatidylethanolamine in which the acyl groups at C-1 and C-2 contain 42 carbons in total with 5 double bonds.


phosphatidylinositol (18:0/18:1)

A phosphatidylinositol 36:1 in which the acyl group at position 1 contains 18 carbons and no double bonds while that at position 2 contains 18 carbons and 1 double bond.


1-acylglycerol 18:1

A 1-monoglyceride in which the acyl group contains 18 carbons and 1 double bond.


A 1-acyl-sn-glycero 3-phospho-(1'-sn-glycerol) in which the acyl group is specified as octadecanoyl (stearoyl).


1-palmitoyl-sn-glycerol 3-phosphate

A 1-acyl-sn-glycerol 3-phosphate having palmitoyl as the acyl group.


A 1-O-alkyl-sn-glycerol in which the alkyl group has a saturated bond between carbons 1 and 2.


Any glycerolipid in which the acyl group at position 2 of the glycerol moiety is specified as (7Z)-hexadec-7-enoyl.


A triacyl-sn-glycerol in which the acyl groups at positions 1, 2 and 3 are specifed as stearoyl, arachidonoyl and oleoyl respectively.


triacylglycerol 46:5

A triglyceride in which the three acyl groups contain a total of 46 carbons and 5 double bonds.


triacylglycerol 54:3

A triglyceride in which the three acyl groups contain a total of 54 carbons and 3 double bonds.


phosphatidylethanolamine (16:1/18:1)

A phosphatidylethanolamine in which one acyl group has 16 carbons and 1 double bond while the other has 18 carbons and 1 double bond.


Any glycerolipid where the 1-acyl group is specified as (6Z,9Z,12Z,15Z)-octadec-6,9,12,15-tetraenoyl.


A 2-monoglyceride where the acyl group is dodecanoyl (lauroyl).


A 1-phosphatidyl-1D-myo-inositol 3-phosphate in which both phosphatidyl acyl groups are specified as octanoyl.


triacylglycerol 52:6

A triglyceride in which the three acyl groups contain a total of 52 carbons and 6 double bonds.


phosphatidic acid 16:0

A phosphatidic acid in which the two acyl groups contain a total of 16 carbons and no double bonds.


A triacylglycerol 44:2 in which the acyl groups at positions 1, 2 and 3 are specified as decanoyl, hexadecenoyl and octadecenoyl respectively.


A glycerolipid where one of the acyl groups is specified as (9Z,12E)-octadecadienoyl.


triacetin

A triglyceride obtained by acetylation of the three hydroxy groups of glycerol. It has fungistatic properties (based on release of acetic acid) and has been used in the topical treatment of minor dermatophyte infections.


A triglyceride where at least the sn-2 position in the glycerol backbone has a linoleoyl chain.


phosphatidylethanolamine (16:0/22:5)

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 22 carbons and 5 double bonds.


Triglycerides which are contained in very low density lipoproteins (VLDL).


phosphatidylglycerol 38:4

A phosphatidylglycerol in which the two acyl groups contain a total of 38 carbons and 4 double bonds.


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (10Z,13Z,16Z)-docosatrienoyl and (9Z,12Z)-hexadecadienoyl respectively.


A 1-acyl-2-tetradecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as tetradecanoyl (myristoyl).


A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and stearoyl respectively.


A glycerolipid where one of the acyl groups is specified as (8E,10E,12Z)-octadecatrienoyl.


cardiolipin (18:3/18:1/18:3/20:3)

A cardiolipin composed from two octadecatrienyl groups, one octadecenyl group and one icosatrieoyl group.


A 3-sn-phosphatidyl-L-serine in which the 1- and 2-acyl groups are octadecanoyl and icosatrienoyl respectively.


phosphatidylglycerol 18:1/18:1

A phosphatidylglycerol 36:1 in which both acyl groups contains 18 carbons and 1 double bond.


triacylglycerol 50:7

A triglyceride in which the three acyl groups contain a total of 50 carbons and 7 double bonds.


lysophosphatidylserine 19:1

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 19 carbons and 1 double bond.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and capryl.


diradylglycerol

Any lipid that is glycerol bearing two substituent groups - either acyl, alkyl, or alk-1-enyl - at any two of the three possible positions.


phosphatidylserine (18:1/20:4)

A phosphatidylserine 38:5 in which the acyl group at C-1 contains 18 carbons and 1 double bond while that at C-2 contains 20 carbons and 4 double bonds.


lysophosphatidylserine 18:4

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 18 carbons and 4 double bonds.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as stearoyl (octadecanoyl) while the phosphatidyl acyl groups are both specified as oleoyl (9Z-octadecenoyl).


A triacyl-sn-glycerol in which the which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, octadecanoyl and (9Z)-octadecenoyl respectively.


A 2-acyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl group is specified as arachidonoyl.


phosphatidylethanolamine (16:0/16:1)

1,2-diacyl-sn-glycero-3-phosphoethanolamine  in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 16 carbons and 1 double bond.


A 1-acyl-sn-glycerol that is the S-enantiomer of  2,3-dihydroxypropyl dodecanoate (glyceryl monolaurate).


triacylglycerol 56:3

A triglyceride in which the three acyl groups contain a total of 56 carbons and 3 double bonds.


A triacylglycerol 60:10 in which the acyl groups at positions 1, 2 and 3 are specified as octadecanoyl, icosatetraenoyl and docosahexaenoyl respectively.


triacylglycerol 53:2

A triglyceride in which the three acyl groups contain a total of 53 carbons and 2 double bonds.


phosphatidylserine 36:2

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 36 carbon atoms and 2 double bonds.


An N-acyl-sn-glycero-3-phosphoethanolamine in which the N-acyl group is specified as arachidonoyl (5Z,8Z,11Z,14Z-icosatetraenoyl).


monoacyl-sn-glycerol 3-phosphate

An sn-glycero-3-phosphate compound having a single unspecified acyl group at either position 1 or position 2.


A monoacylglycerol 20:5 in which the acyl group specified at position 2 is (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl.


phosphatidylserine (18:0/22:5)

A phosphatidylserine 40:5 in which the acyl group at C-1 contains 18 carbons and no double bonds while that at C-2 contains 22 carbons and 5 double bonds.


A triglyceride formed by acylation of the three hydroxy groups of glycerol with palmitoleic acid.


name: 15-methyl-9-hexadecenoic acid 2,3-dihydroxypropyl ester


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as icosanoyl.


phosphatidylethanolamine 36:3

A phosphatidylethanolamine in which the acyl groups at C-1 and C-2 contain 36 carbons in total with 3 double bonds.


cardiolipin (20:2/16:1/18:1/18:3)

A cardiolipin in which the four acyl groups are specified as icosadienoyl, hexadecenoyl, octadecenoyl and octadecatrienoyl.


phosphatidylethanolamine 39:1

A phosphatidylethanolamine in which the two acyl groups contain a total of 39 carbons and 1 double bond.


A glycerolipid where one of the acyl groups is specified as (11Z,14Z,17Z)-icosatrienoyl.


phosphatidylethanolamine 33:2

A phosphatidylethanolamine in which the two acyl groups contain a total of 33 carbons and 2 double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alkenyl and acyl groups are specified as (1Z)-hexadecenyl and linoleoyl respectively.


monooctanoylglycerol

A monoglyceride in which the acyl group is octanoyl with the position of acylation unspecified.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as icosanoyl (arachidoyl) and oleoyl respectively.


A 2-monoglyceride in which the acyl group is specified as (9E)-9-octadecenoyl.


A glycerolipid where one of the acyl groups is specified as gamma-linolenoyl


phosphatidylserine 42:2

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 42 carbon atoms and 2 double bonds.


phosphatidylinositol mannoside

A glycosylphosphatidylinositol having mannose as the glycosyl moiety.


A 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoethanolamine zwitterion in which the Z-alk-1-enyl group contains 18 carbons and has 1 additional double bond


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively.


phosphatidylethanolamine (17:0/22:6)

A phosphatidylethanolamine 39:6 in which the acyl group at C-1 contains 17 carbons and no double bonds while that at C-2 contains 22 carbons and 6 double bonds.


triacylglycerol 51:1

A triglyceride in which the three acyl groups contain a total of 51 carbons and 1 double bond.


monoacylglycerol 16:5

A monoacylglycerol in which the acyl group contains a total of 16 carbons and 5 double bonds.


phosphatidylserine (20:4/20:4)

A phosphatidyl-L-serine in which both acyl groups have 20 carbons and 4 double bonds.


triacylglycerol 50:8

A triglyceride in which the three acyl groups contain a total of 50 carbons and 8 double bonds.


A triacylglycerol 58:9 in which the acyl groups at positions 1, 2 and 3 are specified as octadecenoyl, octadecadienoyl and docosahexaenoyl respectively.


triacylglycerol 60:11

A triglyceride in which the three acyl groups contain a total of 60 carbons and 11 double bonds.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as butyryl while the phosphatidyl acyl groups at position 1 and 2 are specified as palmitoyl (hexadecanoyl) and linoleoyl (9Z,12Z-octadecadienoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-N-methylethanolamine in which the phosphatidyl acyl groups are both specified as oleoyl (9Z-octadecenoyl); major species at pH 7.3.


An N-acyllysophosphatidylethanolamine in which both the N- and O-acyl group are specified as oleoyl (9Z-octadecenoyl).


An N-acyllysophosphatidylethanolamine in which the N-acyl group is specified as arachidonoyl while the phosphatidyl acyl group is specified as oleoyl.


A 1-acyl-2-arachidonoyl-sn-glycero-3-phosphate in which the 1-acyl group is also arachidonoyl.


A triacylglycerol 38:0 in which the acyl groups at positions 1, 2 and 3 are specified as octanoyl, tetradecanoyl and hexadecanoyl respectively.


lysophosphatidylserine 14:0

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 14 carbons and 0 double bonds.


lysophosphatidylinositol 18:2

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 18 carbons and 2 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are specified as (11Z,14Z)-icosadienoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively.


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (8Z,11Z,14Z,17Z)-icosatetraenoyl and (11Z)-octadecenoyl respectively.


A phosphatidylglycerol 36:3 in which one acyl group has 18 carbons and 1 double bond while the other has 18 carbons and 2 double bonds (position not specified).


A triacylglycerol 62:10 in which the acyl groups at positions 1, 2 and 3 are specified as octadecanoyl, docosatetraenoyl and docosahexaenoyl respectively.


A 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.


A phosphatidyl-N-methylethanolamine (1,2-diacylglycero-3-phospho-N-methylethanolamine) in which the stereochemistry of the glycerol moiety is specified as sn.


A phosphatidylinositol 38:4 in which one acyl group has 18 carbons and is fully saturated while the other has 20 carbons and 4 double bonds (position not specified).


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as oleoyl and arachidonoyl respectively.


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl.


glycosylmonoacylglycerol

Any glycosylmonoglyceride in which the glycosyl moiety is attached to one of the primary hydroxy groups and the acyl group position is not defined.


A 2-monoglyceride where the acyl group is tetradecanoyl (myristoyl).


1-(alk-1-enyl)-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl group is specified as (E)-hexadec-1-enyl.


A 1-monoglyceride in which the acyl group is specified as (9E)-octadecenoyl.


A 1-alkyl-2-acylglycerol having acetyl as the acyl substituent.


phosphatidylserine (18:1/22:6)

A phosphatidylserine 40:7 in which the acyl group at C-1 contains 18 carbons and 1 double bond while that at C-2 contains 22 carbons and 6 double bonds.


lysophosphatidic acid 0:0/18:2(9Z,12Z)

A 2-acyl-sn-glycerol 3-phosphate having (9Z,12Z)-octadeca-9,12-dienoyl as the 2-O-acyl group.


lysophosphatidylserine 20:1

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 20 carbons and 1 double bond.


triacylglycerol 55:6

A triglyceride in which the three acyl groups contain a total of 55 carbons and 6 double bonds.


lysophosphatidylethanolamine 20:5

A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 20 carbons and 5 double bonds.


A triglyceride formed by acylation of the three hydroxy groups of glycerol with linolenic acid.


A triacylglycerol 52:3 in which the acyl groups at positions 1, 2 and 3 are specified as palmitoyl, linoleoyl and oleoyl respectively.


distearoyl phosphatidylglycerol

A phosphatidylglycerol in which the phosphatidyl acyl groups are both stearoyl.


triacylglycerol 58:4

A triglyceride in which the three acyl groups contain a total of 58 carbons and 4 double bonds.


A 1-(alk-1-enyl)-2-arachidonoyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl group has Z geochemistry.


lysophosphatidylserine 20:2

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 20 carbons and 1 double bonds.


lysophosphatidylethanolamine 18:2

A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 18 carbons and 2 double bonds.


A 2-acyl-sn-glycero-3-phosphoserine in which the 2-acyl group is specified as arachidonoyl.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl group at position 1 is unspecified while that at position 2 is specified as oleoyl


phosphatidylinositol (16:0/18:1)

A phosphatidylinositol 34:1 in which the acyl group at position 1 contains 16 carbons and no double bonds while that at position 2 contains 18 carbons and 1 double bond.


A phosphatidylglycerol that is the 3'-O-L-lysyl of any 1,2-diacyl-sn-glycero-3-phospho-1'-sn-glycerol.


A 3-(3-sn-phosphatidyl)-sn-glycerol 1-phosphate in which both phosphatidyl acyl groups are specified as hexadecanoyl (palmitoyl).


triacylglycerol 55:10

A triglyceride in which the three acyl groups contain a total of 55 carbons and 10 double bonds.


lysophosphatidylserine 20:5

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 20 carbons and 5 double bonds.


A triacylglycerol 58:4 in which the acyl groups at positions 1, 2 and 3 are specified as octadecanoyl, icosanoyl and icosatetraenoyl respectively.


A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alkenyl and acyl groups are specified as (1Z)-octadecenyl and linoleoyl respectively.


triacylglycerol 42:4

A triglyceride in which the three acyl groups contain a total of 42 carbons and 4 double bonds.


A triacylglycerol 44:2 in which the acyl groups at positions 1, 2 are specified as tetradecenoyl while that at position 3 is specified as hexadecanoyl.


glycerophosphoinositol trisphosphate

Any glycerophosphoinositol bearing three additional phospho substituents on the inositol ring.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the acyl group at position 1 is unspecified while that at position 2 is specified as palmitoyl.


A 2-monoglyceride in which the acyl group is specified as (9E,12E,15E)-octadecatrienoyl.


A glycerolipid where one of the acyl groups is specified as (7Z,10Z,13Z,16Z)-docosatetraenoyl.


triacylglycerol 52:3

A triglyceride in which the three acyl groups contain a total of 52 carbons and 3 double bonds.


CDP-acylglycerol

A CDP-glycerol compound having an acyl substituent on its primary hydroxyl group.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and capryloyl.


A 1-monoglyceride that has alpha-linolenoyl as the acyl group.


phosphatidylglycerol (18:3/16:0)

A phosphatidylglycerol 34:3 in which the 1- and 2-acyl groups are specified as octadecatrienoyl and hexadecanoyl respectively.


A phosphatidylethanolamine 35:2 in which the acyl group at C-1 contains 18 carbons and 1 double bond while that at C-2 contains 17 carbons and 1 double bond.


triacylglycerol 55:5

A triglyceride in which the three acyl groups contain a total of 55 carbons and 5 double bonds.


phosphatidylglycerol 12:0

A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the acyl groups at C-1 and C-2 contain 12 carbons in total with no double bonds.


triacylglycerol 55:2

A triglyceride in which the three acyl groups contain a total of 55 carbons and 2 double bonds.


LYSOPHOSPHATIDIC ACID

A 1-acyl-sn-glycerol 3-phosphate having oleoyl as the 1-O-acyl group.


A glycerolipid where one of the acyl groups is specified as (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl.


trilinoleoyl 2-monolysocardiolipin

A 2-monolysocardiolipin in which all three phosphatidyl acyl groups are specified as linoleoyl.


name: Hepatitis Virus-Related Hepatocellular Carcinoma

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: A hepatocellular carcinoma that develops following hepatitis virus exposure and injury of the liver parenchyma.


Stage IIIA Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage IIIA includes: T3a, N0, M0. T3a: Multiple tumors more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


name: Epithelioid hemangioendothelioma of liver

description: A low-grade malignant blood vessel neoplasm that arises from the liver.  It is characterized by the presence of epithelioid endothelial cells.  The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.  Patients may be asymptomatic or present with an abdominal mass, ascites, and jaundice.


name: Stage I Intrahepatic Bile Duct Cancer AJCC v8

description: Stage I includes: IA (T1a, N0, M0); IB (T1b, N0, M0). T1a: Solitary tumor equal to or less than 5 cm without vascular invasion.  T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Unresectable Fibrolamellar Carcinoma

description: A fibrolamellar carcinoma that is not amenable to surgical resection.


name: Hepatoblastoma with Pure Fetal Epithelial Differentiation

description: A hepatoblastoma composed of small cells resembling the fetal hepatocytes, forming thin trabeculae.


name: Recurrent Adult Hepatocellular Carcinoma

description: A hepatocellular carcinoma that occurs during adulthood and has recurred after a period of remission.


name: Locally Advanced Hepatocellular Carcinoma

description: Hepatocellular carcinoma that has spread to nearby tissues or lymph nodes.


Hepatoblastoma recurrent

description: The reemergence of hepatoblastoma after a period of remission.


name: Stage IV Childhood Hepatocellular Carcinoma AJCC v7

description: Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis.  M1: Distant metastasis. (AJCC 7th ed.)


BCLC Stage 0 Hepatocellular Carcinoma

description: Very early hepatocellular carcinoma. Patients are optimal candidates for resection. (HPB (Oxford) 2005; 7(1):35-41)


BCLC Stage D Hepatocellular Carcinoma

description: End-stage hepatocellular carcinoma.  Patients will receive symptomatic treatment. (HPB (Oxford) 2005; 7(1):35-41)


Localized PRETEX III Hepatoblastoma

description: PRETEX III hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Adult Liver Carcinoma

description: A hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood.


Liver Synovial Sarcoma

description: A synovial sarcoma that affects the liver.


Stage IV Liver Cancer

description: Stage IV carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.


Metastatic Fibrolamellar Carcinoma

description: A fibrolamellar carcinoma that has spread from the liver to another anatomic site.


name: Stage III Hepatocellular Carcinoma AJCC v7

description: Stage III includes: IIIA: (T3a, N0, M0); IIIB: (T3b, N0, M0); IIIC: (T4, N0, M0). T3a: Multiple tumors more than 5 cm. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


name: Stage IVA Hepatocellular Carcinoma AJCC v7

description: Stage IVA includes: Any T, N1, M0.  N1: Regional lymph node metastasis. M0: No distant metastasis.  (AJCC 7th ed.)


PRETEXT IV Hepatoblastoma

description: An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves all 4 quadrants; there is no quadrant free of tumor. (from PDQ 2004)


Non-Resectable Malignant Liver Neoplasm

description: A malignant liver neoplasm that is not amenable to surgical resection.


Metastatic liver carcinoma

description: A carcinoma that arises from the liver and has spread to another anatomic site.


name: Adult Pleomorphic Hepatocellular Carcinoma

description: A pleomorphic hepatocellular carcinoma that occurs during adulthood.


name: Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 2

description: A term that refers to the staging of childhood hepatoblastoma according to the tier 2 Toronto childhood cancer staging guidelines v2. It includes localized tumors, metastatic tumors, and the PRETEXT system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Stage IV Hepatocellular Carcinoma AJCC v7


name: BCLC Stage C Adult Hepatocellular Carcinoma

description: Advanced hepatocellular carcinoma.  Patients may receive new agents in the setting of randomized controlled trials. (HPB (Oxford) 2005; 7(1):35-41)


name: Stage IV Hepatocellular Carcinoma AJCC v6

description: Stage IV includes (Any T, Any N, M1).  M1: Distant metastasis. (AJCC 6th ed.)


Extrarenal Rhabdoid Tumor of the Liver

description: A rare, aggressive primary malignant tumor of the liver that occurs in childhood.  It is characterized by the presence of a diffuse infiltrate of undifferentiated cells with rhabdoid features.


Adult Liver Embryonal Sarcoma

description: An embryonal sarcoma of the liver that occurs during adulthood.


Stage II Liver Cancer

description: Stage II carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.


Postsurgical Stage III Hepatoblastoma

description: No distant metastases, tumor unresectable or resected with gross residual tumor, or positive lymph nodes. (from PDQ 2004)


PRETEXT III Hepatoblastoma

description: An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves 3 adjoining quadrants or 2 nonadjoining quadrants; 1 quadrant or 2 nonadjoining quadrants are free of tumor. (from PDQ 2004)


Refractory Hepatoblastoma

description: Hepatoblastoma that does not respond to treatment.


Uveal Melanoma Metastatic in the Liver

description: A melanoma that originates from melanocytes of the uveal tract and has spread to the liver.


name: Stage II Hepatocellular Carcinoma AJCC v8

description: Stage II includes: T2, N0, M0. T2: Solitary tumor larger than 2 cm with vascular invasion, or multiple tumors, none larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Liver Small Cell Neuroendocrine Carcinoma

description: An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver. It is characterized by the presence of malignant small cells.


name: Stage IV Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)


name: Stage IIIA Hepatocellular Carcinoma AJCC v7

description: Stage IIIA includes: T3a, N0, M0.  T3a: Multiple tumors more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


Stage III Liver Cancer

description: Stage III carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.


name: Epithelial Hepatoblastoma with Pleomorphic Pattern

description: Epithelial hepatoblastoma characterized by the presence of fetal or embryonal cells showing nuclear pleomorphism. Malignant giant cells may be present.


Stage IIIC Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage IIIC includes: T4, N0, M0.  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


name: Stage I Hepatocellular Carcinoma AJCC v6 and v7

description: Stage I includes: T1, N0, M0.  T1: Solitary tumor without vascular invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)


Colon Carcinoma Metastatic in the Liver

description: A carcinoma that originates from the colonic wall and has spread to the liver.


name: Stage III Hepatocellular Carcinoma AJCC v8

description: Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0). T3: Multiple tumors, at least one of which is larger than 5 cm. T4: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein, or tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Non-Teratoid Hepatoblastoma

description: A mixed epithelial and mesenchymal hepatoblastoma characterized by the absence of heterologous elements, muscle, cartilage or osteoid.


name: Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IIIA includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Liver Mixed Adenoneuroendocrine Carcinoma

description: A carcinoma that arises from the liver and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.


name: Moderately Differentiated Hepatocellular Carcinoma

description: A hepatocellular carcinoma characterized by the presence of malignant cells with abundant eosinophilic cytoplasm forming trabecular and pseudoglandular patterns.  It is usually associated with tumors that are larger than 3 cm in diameter.


name: Hepatocellular carcinoma, spindle cell variant

description: A morphologic variant of hepatocellular carcinoma characterized by the presence of malignant spindle cells or atypical giant cells.


carcinosarcoma of liver

description: An aggressive carcinoma with a sarcomatous component that arises from the liver.  The sarcomatous component is clonally related to the more differentiated, carcinomatous component.  The prognosis is usually poor.


Hepatic cancer stage IVA

description: Stage IVA carcinoma of the liver according to the American Joint Committee on Cancer, 7th and 8th editions.


name: Stage II Intrahepatic Bile Duct Cancer AJCC v8

description: Stage II includes: T2, N0, M0. T2: Solitary tumor with intrahepatic vascular invasion, or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Hepatocellular Malignant Neoplasm, Not Otherwise Specified

description: A rare childhood malignant liver neoplasm with overlapping features of hepatoblastoma and hepatocellular carcinoma.


name: Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7


Locally Advanced Liver Carcinoma

description: Liver carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


Teratoid Hepatoblastoma

description: A mixed epithelial and mesenchymal hepatoblastoma characterized by the presence of heterologous elements. The latter include neuroectoderm, endoderm, or melanin-holding cells. Muscle, cartilage and osteoid may or may not be present.


BCLC Stage B Hepatocellular Carcinoma

description: Intermediate hepatocellular carcinoma.  Patients may benefit from chemoembolization. (HPB (Oxford) 2005; 7(1):35-41)


Kaposi's sarcoma of liver

description: A Kaposi sarcoma that arises from the liver.


name: Stage IA Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IA includes: T1a, N0, M0. T1a: Solitary tumor equal to or less than 5 cm without vascular invasion.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


description: Hepatocellular carcinoma characterized by the presence of diffuse neutrophil infiltrates within the tumor.


Stage IIIB Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage IIIB includes: T3b, N0, M0. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


name: Childhood Hepatoblastoma by Toronto Guidelines v2 Stage

description: A term that refers to the staging of childhood hepatoblastoma according to the Toronto childhood cancer staging guidelines v2.


Metastatic malignant neoplasm to liver

description: A malignant neoplasm that has spread to the liver from another (primary) anatomic site. Representative examples include carcinomas, lymphomas, melanomas, or sarcomas.


name: Stage 0 Intrahepatic Bile Duct Cancer AJCC v8

description: Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (intraductal tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Metastatic hepatocellular carcinoma

description: A hepatocellular carcinoma that has spread to another anatomic site.


name: Unresectable Liver and Intrahepatic Bile Duct Carcinoma

description: Liver carcinoma that is not amenable to surgical resection.


Childhood Liver Embryonal Sarcoma

description: An embryonal sarcoma of the liver that occurs during childhood.


name: Recurrent Childhood Hepatocellular Carcinoma

description: A hepatocellular carcinoma that occurs during childhood and has recurred after a period of remission.


Malignant Liver Non-Epithelial Neoplasm

description: A primary or metastatic malignant non-epithelial neoplasm that affects the liver.


name: BCLC Stage B Adult Hepatocellular Carcinoma


name: Hepatocellular Carcinoma by AJCC v8 Stage

description: A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to hepatocellular carcinomas and fibrolamellar carcinomas (fibrolamellar variant of hepatocellular carcinoma). Intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas, and sarcomas of the liver are not staged using this staging system. (from AJCC 8th Ed.)


description: A hepatocellular carcinoma that arises in a patient with a history of organ transplantation.


name: Hepatitis B Virus-Related Hepatocellular Carcinoma

description: A hepatocellular carcinoma that develops following hepatitis B virus exposure and injury of the liver parenchyma.


name: Hepatitis C Virus-Related Hepatocellular Carcinoma

description: A hepatocellular carcinoma that develops following hepatitis C virus exposure and injury of the liver parenchyma.


name: BCLC Stage 0 Adult Hepatocellular Carcinoma

description: Very early hepatocellular carcinoma. Patients are optimal candidates for resection. (HPB (Oxford) 2005; 7(1):35-41)


name: Localized Non-Resectable Adult Liver Carcinoma

description: A localized hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood and it is not amenable to surgical resection.


Recurrent Childhood Liver Cancer

description: A malignant neoplasm of the liver that occurs during childhood and has recurred after a period of remission.


Liver Yolk Sac Tumor

description: A yolk sac tumor that arises from the liver.


Stage I Liver Carcinoma

description: Stage I carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.


name: Colorectal Adenocarcinoma Metastatic in the Liver

description: An adenocarcinoma that originates from the colorectal area and has spread to the liver.


name: Stage IV Hepatocellular Carcinoma AJCC v8

description: Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)


Postsurgical Stage IV Hepatoblastoma

description: Distant metastases, regardless of the extent of liver involvement. (from PDQ 2004)


name: Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier1

description: Tumor confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Small Cell Undifferentiated Hepatoblastoma

description: A hepatoblastoma composed exclusively of noncohesive sheets of small undifferentiated cells. Cases showing loss of INI1 nuclear staining should be classified as rhabdoid tumors.


name: Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2

description: Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Postsurgical Stage I Hepatoblastoma

description: No metastases, tumor completely resected. (from PDQ 2004)


name: Well Differentiated Hepatocellular Carcinoma

description: A hepatocellular carcinoma characterized by the presence of malignant cells with mild atypia and an increased nuclear/cytoplasmic ratio forming thin trabecular patterns.  It is usually associated with small tumors and an early stage.


name: Stage IB Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IB includes: T1b, N0, M0. T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Childhood Fibrolamellar Carcinoma

description: A fibrolamellar variant of hepatocellular carcinoma that occurs during childhood.


Recurrent Liver Carcinoma

description: The reemergence of liver carcinoma after a period of remission.


name: Stage IVA Hepatocellular Carcinoma AJCC v8

description: Stage IVA includes: Any T, N1, M0. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: BCLC Stage A Adult Hepatocellular Carcinoma

description: Early hepatocellular carcinoma.  Patients are candidates for radical therapies (resection, liver transplantation, or percutaneous treatments). (HPB (Oxford) 2005; 7(1):35-41)


Metastatic Hepatoblastoma

description: Hepatoblastoma that has spread from its original site of growth to another anatomic site.


name: Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 1

description: A term that refers to the staging of childhood hepatoblastoma according to the tier 1 Toronto childhood cancer staging guidelines v2.


Stage II Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis.  For intrahepatic cholangiocarcinoma: Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)


name: Stage III Childhood Hepatocellular Carcinoma AJCC v7

description: Stage III includes: IIIA: (T3a, N0, M0); IIIB: (T3b, N0, M0); IIIC: (T4, N0, M0). T3a: Multiple tumors more than 5 cm. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


Hepatoblastoma by PRETEXT Stage

description: A term that refers to the staging of hepatoblastoma, following the rules of the PRETEXT (pre-treatment extent of tumor) system.


Localized PRETEX I Hepatoblastoma

description: PRETEX I hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Hepatoblastoma resectable

description: Hepatoblastoma amenable to surgical removal.


name: Stage IVB Hepatocellular Carcinoma AJCC v8

description: Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)


name: Hepatocellular Carcinoma by AJCC v7 Stage

description: A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 7th edition.


name: Stage IIIB Hepatocellular Carcinoma AJCC v8

description: Stage IIIB includes: T4, N0, M0. T4: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein, or tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Localized Unresectable Adult Hepatocellular Carcinoma

description: A localized hepatocellular carcinoma that occurs during adulthood and it is not amenable to surgical resection.


Adult Fibrolamellar Carcinoma

description: Fibrolamellar variant of hepatocellular carcinoma that occurs during adulthood.


name: Poorly Differentiated Hepatocellular Carcinoma

description: A hepatocellular carcinoma characterized by the presence of malignant pleomorphic cells forming solid patterns.


Recurrent Fibrolamellar Carcinoma

description: The reemergence of fibrolamellar carcinoma after a period of remission.


undifferentiated carcinoma of liver

description: A rare carcinoma that arises from the liver.  The diagnosis is made by immunohistochemical studies.  Morphologic studies alone cannot establish the diagnosis of carcinoma or further subclassify the malignant tumor.


description: A hepatocellular carcinoma that develops following alcohol-induced injury of the liver parenchyma.


name: Stage IVB Hepatocellular Carcinoma AJCC v7

description: Stage IVB includes: Any T, Any N, M1.  M1: Distant metastasis. (AJCC 7th ed.)


BCLC Stage C Hepatocellular Carcinoma

description: Advanced hepatocellular carcinoma.  Patients may receive new agents in the setting of randomized controlled trials. (HPB (Oxford) 2005; 7(1):35-41)


Stage I Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis.  For intrahepatic cholangiocarcinoma: Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)


Small Hepatocellular Carcinoma

description: Hepatocellular carcinoma measuring equal to or less than 2 cm in diameter. It includes early hepatocellular carcinoma and small progressed hepatocellular carcinoma.


Hepatoblastoma by Postsurgical Stage

description: A term that refers to the staging of hepatoblastoma according to post-operative findings.


Pleomorphic Hepatocellular Carcinoma

description: A morphologic variant of hepatocellular carcinoma, characterized by the presence of malignant cells which show marked variation in their size and shape. Bizarre mononuclear or multinucleated giant cells are often present.


name: Stage IIIB Hepatocellular Carcinoma AJCC v7

description: Stage IIIB includes: T3b, N0, M0. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


Stage III Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage III includes: IIIA: (T3a, N0, M0); IIIB: (T3b, N0, M0); IIIC: (T4, N0, M0). T3a: Multiple tumors more than 5 cm. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis.  For intrahepatic cholangiocarcinoma: Stage III includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum or involving the local extra hepatic structures by direct invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)


name: large cell neuroendocrine carcinoma of liver

description: An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver. It is characterized by the presence of malignant large cells.


PRETEXT I Hepatoblastoma

description: An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves only 1 quadrant; 3 adjoining liver quadrants are free of tumor. (from PDQ 2004)


name: Hepatocellular Carcinoma by AJCC v6 Stage

description: A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 6th edition.


Childhood Liver Angiosarcoma

description: An angiosarcoma that arises from the liver during childhood. Most cases arise within preexisting liver infantile hemangiomas.


Epithelial Hepatoblastoma

description: A subtype of hepatoblastoma characterized by the presence of an epithelial component and absence of mesenchymal elements. It includes hepatoblastoma with pure fetal epithelial differentiation, hepatoblastoma with combined fetal and embryonal epithelial differentiation, macrotrabecular hepatoblastoma, and small cell undifferentiated hepatoblastoma (small cell undifferentiated hepatoblastoma with loss of INI1 nuclear staining should be classified as rhabdoid tumor).


Hepatocellular Carcinoma by BCLC Stage

description: A staging classification system for hepatocellular carcinoma that uses variables related to tumor stage, liver functional status, physical status, and cancer-related symptoms, and links the stages with a treatment algorithm. (HPB (Oxford) 2005; 7(1):35-41)


name: Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 1

description: Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Hepatoblastoma non-resectable

description: Hepatoblastoma not amenable to surgical removal.


name: Intrahepatic Bile Duct Cancer by AJCC v8 Stage

description: A term that refers to the staging of intrahepatic bile duct cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas (mixed hepatocholangiocarcinomas), and primary neuroendocrine tumors of the liver. Primary sarcomas of the liver, pure hepatocellular carcinomas, hilar cholangiocarcinomas, and gallbladder carcinomas are not staged using this staging system. (from AJCC 8th Ed.)


name: Stage III Intrahepatic Bile Duct Cancer AJCC v8

description: Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); (Any T, N1, M0). T3: Tumor perforating the visceral peritoneum. T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Chromophobe Hepatocellular Carcinoma

description: Hepatocellular carcinoma characterized by the presence of malignant cells with smooth chromophobic cytoplasm, abrupt focal nuclear anaplasia, and scattered microscopic pseudocysts.


Recurrent Hepatocellular Carcinoma

description: The reemergence of hepatocellular carcinoma after a period of remission


BCLC Stage A Hepatocellular Carcinoma

description: Early hepatocellular carcinoma.  Patients are candidates for radical therapies (resection, liver transplantation, or percutaneous treatments). (HPB (Oxford) 2005; 7(1):35-41)


Refractory Liver Carcinoma

description: Liver carcinoma that is resistant to treatment.


Stage IVB Liver Cancer

description: Stage IVB carcinoma of the liver according to the American Joint Committee on Cancer, 7th and 8th editions.


Metastatic PRETEX III Hepatoblastoma

description: PRETEX III hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Refractory Hepatocellular Carcinoma

description: Hepatocellular carcinoma that is resistant to treatment.


Localized PRETEX II Hepatoblastoma

description: PRETEX II hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Metastatic carcinoma to liver

description: A carcinoma that has spread to the liver from another primary anatomic site.  Representative examples include metastatic carcinomas from the colon, breast, and lung.


name: Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2

description: Tumor confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Early Hepatocellular Carcinoma

description: A low grade, well differentiated small hepatocellular carcinoma. It lacks obvious stromal invasion and significant atypia.


Metastatic PRETEX IV Hepatoblastoma

description: PRETEX IV hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Liver Plasmacytoma

description: A plasmacytoma that arises in the liver.


name: Stage II Hepatocellular Carcinoma AJCC v6 and v7

description: Stage II includes: T2, N0, M0.  T2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)


description: A rare type of hepatocellular carcinoma characterized by the presence of pleomorphic malignant cells that are intermixed with lymphocytes.


name: Stage III Hepatocellular Carcinoma AJCC v6

description: Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); IIIC: (Any T, Any N, M0).  IIIA: T3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s).  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum.  N0: No regional lymph node metastasis.  N1: Regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th ed.)


PRETEXT II Hepatoblastoma

description: An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves 2 adjoining quadrants; 2 adjoining quadrants are free of tumor. (from PDQ 2004)


Stage IV Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis.  For intrahepatic cholangiocarcinoma: Stage IVA includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor with periductal invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis.  Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 7th Ed.)


Unresectable Hepatocellular Carcinoma

description: A hepatocellular carcinoma that is not amenable to surgical resection.


name: Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation

description: A hepatoblastoma composed of cells resembling fetal epithelial cells and small round cells resembling blastema cells.


name: Rectal Carcinoma Metastatic in the Liver

description: A carcinoma that originates from the rectum and has spread to the liver.


name: Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma

description: A combined hepatocellular carcinoma and cholangiocarcinoma that occurs during adulthood.


name: Stage IIIA Hepatocellular Carcinoma AJCC v8

description: Stage IIIA includes: T3, N0, M0. T3: Multiple tumors, at least one of which is larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IIIC Hepatocellular Carcinoma AJCC v7

description: Stage IIIC includes: T4, N0, M0.  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


Childhood Malignant Liver Neoplasm

description: A malignant neoplasm that affects the liver and occurs during childhood.


name: BCLC Stage D Adult Hepatocellular Carcinoma

description: End-stage hepatocellular carcinoma.  Patients will receive symptomatic treatment. (HPB (Oxford) 2005; 7(1):35-41)


name: Macrotrabecular Massive Hepatocellular Carcinoma

description: Hepatocellular carcinoma characterized by more than 50% growth of macrotrabecular pattern (equal to or more than 6 to 10 cells thick). It presents with higher grade and stage compared to conventional hepatocellular carcinoma. It has poor prognosis with early recurrence and poor overall survival.


name: Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7


Metastatic PRETEX II Hepatoblastoma

description: PRETEX II hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Early Stage Hepatocellular Carcinoma

description: A stage term referring to hepatocellular carcinoma that presents as a single tumor with the largest diameter measuring 2 cm or less. The liver function is well-preserved and there is no vascular invasion or metastasis. (Barcelona Liver Cancer Classification).


name: Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IIIB includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


description: Hepatocellular carcinoma characterized by the presence of steatohepatitis features, including macrovesicular steatosis, fibrosis, ballooning of malignant hepatocytes, Mallory bodies, and inflammation.


name: Colorectal Carcinoma Metastatic in the Liver

description: A carcinoma that originates from the colorectal area and has spread to the liver.


Metastatic PRETEX I Hepatoblastoma

description: PRETEX I hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Small Progressed Hepatocellular Carcinoma

description: A well to moderately differentiated small hepatocellular carcinoma. It is characterized by the presence of obvious stromal invasion and increase atypia compared with early hepatocellular carcinoma.


Recurrent Adult Liver Carcinoma

description: A hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood and has recurred after a period of remission.


rifamycin-undecaketide carboxy group

A univalent carboacyl group formed by loss of OH from the carboxy group of rifamycin-undecaketide carboxylic acid


yanuthone F

A class I yanuthone that is 7-deacetoxyyanuthone A in which one of the hydrogens of the trans-terminal methyl groups of the sesquiterpenoid side-chain has been replaced by a hydroxy group.


2,6-dioxo-6-phenylhexanoic acid

A dioxo monocarboxylic acid consisting of 6-phenylhexanoic acid having the two oxo groups at the 2- and 6-positions.


name: Grade II Prostatic Intraepithelial Neoplasia

description: High grade prostatic intraepithelial neoplasia characterized by the presence of moderate architectural and cytologic abnormalities.


name: Testicular Tumor of the Thecoma/Fibroma Group

description: A group of rare, slow-growing stromal tumors that arise from the testis.  This category includes thecoma and fibroma.


Testicular Signet Ring Stromal Tumor

description: An extremely rare tumor that arises from the testis. It is characterized by the proliferation of epithelioid cells with signet ring appearance separated by fibrous tissue into trabeculae and nests. The histologic features are bland and there is no mucin production. Mutations of CTNNB1 gene have been identified in the reported cases. It is considered a special type of sex cord-stromal tumor. All reported cases had a benign clinical course without metastases.


name: recurrent childhood acute myeloid leukemia

description: The reemergence of acute myeloid leukemia in childhood after a period of remission.


Arg-Ile

A dipeptide formed from L-arginyl and L-isoleucine residues.


A phosphatidylethanolamine 34:0 zwitterion in which the acyl groups at positions 1 and 2 are both specified as heptadecanoyl.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 34 carbons in total with 0 double bonds.


A phosphatidylethanolamine 34:1 zwitterion obtained by transfer of a proton from the phosphate to the amino group of 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphoethanolamine.


(-)-coronaridine

A monoterpenoid indole alkaloid with formula C21H26N2O2. It is isolated from the flowering plant genus, Tabernaemontana.


A secondary fatty alcohol that is hexacosane substituted by a hydroxy group at position 13.


name: Stage IV Gestational Trophoblastic Neoplasm AJCC v8

description: Stage IV includes: Any T, M1b. M1b: Gestational trophoblastic neoplasm with all other distant metastases. (AJCC 8th Ed.)


name: Childhood Unfavorable Prognosis Hodgkin Lymphoma

description: A Hodgkin lymphoma with unfavorable prognosis that occurs during childhood.


Acquired Factor III Deficiency

description: An acquired coagulation disorder characterized by the partial or complete absence of tissue factor (factor III) activity in the blood.


Factor III deficiency

description: A coagulation disorder characterized by the partial or complete absence of tissue factor (factor III) activity in the blood.


Factor III Inactivation

description: Presence of inactivating antibodies to tissue factor (factor III) in the blood.


Hereditary Factor III Deficiency

description: An autosomal recessive, inherited coagulation disorder characterized by the partial or complete absence of tissue factor (factor III) activity in the blood.


A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazole substituted at positions 2 and 5 by 4-ethylphenyl and 3-nitrobenzamido groups respectively.


Acardius

description: A severe form of twin-twin transfusion syndrome that occurs in monochorionic pregnancies. The normal twin (pump twin) supplies the blood flow to its sibling that lacks heart or brain or both (acardiac/acephalic twin). Untreated, it may lead to the demise of the pump twin in some cases.


Parkinson Disease 9

description: An autosomal recessive subtype of Parkinson disease, caused by mutation(s) in the ATP13A2 gene, encoding polyamine-transporting ATPase 13A2.


name: Parkinson Disease 23, Autosomal Recessive, Early Onset

description: An autosomal recessive subtype of Parkinson disease, caused by mutation(s) in the VPS13C gene, encoding intermembrane lipid transfer protein VPS13C.


Parkinson Disease 20, Early-Onset

description: An autosomal recessive subtype of Parkinson disease, caused by mutation(s) in the SYNJ1 gene, encoding synaptojanin-1.


desertorin A

A bicoumarin that is 7-hydroxy-4-methoxy-5-methyl-2H-chromen-2-one substituted by a 7-hydroxy-4-methoxy-5-methyl-2-oxo-2H-chromen-6-yl group at position 8.


isotridecanoyl-CoA

A methyl-branched fatty acyl-CoA obtained from the formal condensation of the thiol group of coenzyme A with the carboxy group of isotridecanoic acid


Benign neoplasm of supraglottis

description: A neoplasm that arises from the supraglottis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.


name: Childhood Acute Myeloid Leukemia without Maturation

description: An acute myeloid leukemia without maturation occurring in children.


A member of the class of anthracyclines that is beta-rhodomycin lacking the phenolic hydroxy group at position 11.


That one of the three tautomers of pyrrole which has the double bonds at positions 1 and 4.


Parasite-Related Carcinoma

description: A term that refers to a group of carcinomas that are caused by parasites.


name: Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma

description: A squamous cell carcinoma of the bladder that is caused by Schistosoma hematobium.


name: Schistosoma Hematobium-Related Bladder Verrucous Carcinoma

description: A verrucous squamous cell carcinoma of the bladder that is caused by Schistosoma hematobium.


A secondary carboxamide resulting from the formal condensation of the carboxy group of 4-sulfamoylbenzoic acid with the amino group of 1-phenylmethanamine. It is a potent inhibitor of carbonic anhydrase II.


pyrylium salt

Any salt of pyrylium or its derivatives


1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at positions 1 and 2 are both specified as hexanoyl.


(S)-idazoxan

An idazoxan that has S configuration.


squamous epithelial cell

category: biolink:Cell biolink:AnatomicalEntity biolink:PhysicalEssence biolink:OrganismalEntity biolink:SubjectOfInvestigation biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent


name: outer medulla vasa recta ascending limb cell

description: Any vasa recta ascending limb cell that is part of some outer medulla vasa recta ascending limb.


hair follicular keratinocyte

description: Any keratinocyte that is part of a hair follicle.


name: inner medulla vasa recta descending limb cell

description: Any vasa recta descending limb cell that is part of some inner medulla vasa recta descending limb.


dermis blood vessel endothelial cell

description: Any blood vessel endothelial cell that is part of a dermis.


name: kidney cortex peritubular capillary cell

description: Any peritubular capillary endothelial cell that is part of some renal cortex peritubular capillary.


aortic endothelial cell

description: An arterial endothelial cell that is part of the aorta endothelium.


name: vein endothelial cell of respiratory system

description: A(n) vein endothelial cell that is part of a(n) respiratory system.


bladder microvascular endothelial cell

description: Any microvascular endothelial cell that is part of a urinary bladder.


umbilical artery endothelial cell

description: Any endothelial cell of artery that is part of a umbilical cord.


Merkel cell

description: A modified epidermal cell located in the stratum basale. They are found mostly in areas where sensory perception is acute. Merkel cells are closely associated with an expanded terminal bulb of an afferent myelinated nerve fiber.


endothelial tip cell

description: A specialized endothelial cell that senses extracellular signals and guides the directed growth of blood vessels.


peritubular capillary endothelial cell

description: An endothelial cell that is part of some peritubular capillary.


name: outer medulla vasa recta descending limb cell

description: Any vasa recta descending limb cell that is part of some outer medulla vasa recta descending limb.


mammary microvascular endothelial cell

description: Any microvascular endothelial cell that is part of a breast.


vasa recta descending limb cell

description: A cell that is part of some vasa recta descending limb.


ovarian microvascular endothelial cell

description: Any microvascular endothelial cell that is part of a female urethra.


mesothelial cell of small intestine

description: A mesothelial cell that is part of the small intestine.


endothelial stalk cell

description: An endothelial stalk cell is a specialized endothelial cell that follows behind the tip cell of an angiogenic sprout.


adipose microvascular endothelial cell

description: Any microvascular endothelial cell that is part of a adipose tissue.


name: kidney efferent arteriole endothelial cell

description: Any endothelial cell that is part of some renal efferent arteriole.


name: endothelial cell of arteriole of lymph node

description: A(n) endothelial cell that is part of a(n) arteriole of lymph node.


keratinized cell of hair follicle

description: A hair follicle matrix region cell which synthesizes keratin and undergoes a characteristic change as it moves upward from the hair bulb to become the hair medulla cortex and hair root sheath.


name: inner medulla vasa recta ascending limb cell

description: Any vasa recta ascending limb cell that is part of some inner medulla vasa recta ascending limb.


pulmonary artery endothelial cell

description: Any endothelial cell of vascular tree that is part of some pulmonary artery.


microvascular endothelial cell

description: Any blood vessel endothelial cell that is part of a microvascular endothelium.


vasa recta cell

description: A cell that is part of a vasa recta.


name: endometrial microvascular endothelial cell

description: Any microvascular endothelial cell that is part of a endometrial blood vessel.


interlobulary vein endothelial cell

description: Any endothelial cell that is part of some renal interlobular vein.